Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Q BioMed Market Cap
Q BioMed has a market cap or net worth of $145 as of January 23, 2026.
Market Cap
145.00
Enterprise Value
n/a
Revenue
209.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 17, 2015, Q BioMed's market cap has decreased from 12.19M to 145.00, a decrease of -100.00%. That is a compound annual growth rate of -65.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 145.00 | -99.00% |
| Dec 31, 2025 | 14.51K | 9,906.21% |
| Dec 31, 2024 | 145.00 | -99.75% |
| Dec 29, 2023 | 58.04K | -93.87% |
| Dec 30, 2022 | 947.29K | -92.38% |
| Dec 31, 2021 | 12.44M | -46.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| NexImmune | 139.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |
| ContraFect | 107.00 |